study to find out the efficacy of 0.75% ropivacaine alone or with dexmedetomidine in upper limb suregries.

A Comparative study to evaluate the efficacy of 0.75% Ropivacaine alone or combined with dexmedetomidine in supraclavicular brachial plexus block in upper limb surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059111

Enrollment

120

Registered

2023-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M859- Disorder of bone density and structure, unspecified

Interventions

Control Intervention1: 0.75% ROPIVACAINE: Ropivacaine is an aminoamide local anesthetic drug. It is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute p

Eligibility

Inclusion criteria

Inclusion criteria: 120 patients of either sex, aged 18—60 years, belonging to American Society of Anesthesiologists (ASA) physical status class I and Il presenting for upper limb elective surgery under supraclavicular block.

Exclusion criteria

Exclusion criteria: Who refuse to give consent. With severe cardiac, renal, endocrine, pulmonary disease. In physical status ASA grade Ill or higher. Who are allergic to trial drugs. Who are having local site infection. With hemi-diaphragmatic paralysis on opposite side of surgery With any psychological disorder who would interfere with assessment of pain. With history of brachial plexus injury. With bilateral upper limb surgery and fracture. With heart rate already on the lower side i.e 55 or less than 55b/m.

Design outcomes

Primary

Measure	Time frame
To determine whether the efficacy of 0.75% Ropivacaine with dexmedetomidine is greater than 0.75% Ropivacaine used alone in supraclavicular brachial plexus block for upper limb surgeries. Timepoint: Onset & duration of Sensory block. Onset and duration of motor block. Duration of analgesia.	—

Secondary

Measure	Time frame
To compare the Hemodynamic parameters Complications. Timepoint: To compare the Hemodynamic parameters Complications.	—

Countries

India

Contacts

Public ContactDR SUMITRA KANOJIYA

MAHARAJA GRASEN MEDICAL COLLEGE,AGROHA.

DRSUMITRAKANOJIYA@GMAIL.COM8307994393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026